Back
Ligand Pharmaceuticals Quote, Financials, Valuation and Earnings
Sponsored
LGND
Sponsored
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
40
LGND
Ligand Pharmaceuticals
Last Price:
80.30
Seasonality Move:
4.37%
7 Day Trial
ALL ACCESS PASS
$
7
America's Final Republican President
Click here to see his 2024 election prediction.Ligand Pharmaceuticals Price Quote
$80.30
+6.92 (+9.43%)
(Updated: May 8, 2024 at 6:55 PM ET)
Ligand Pharmaceuticals Key Stats
Sell
40
Ligand Pharmaceuticals (LGND)
is a Sell
Day range:
$73.16 - $75.62
52-week range:
$49.24 - $94.57
Dividend yield:
0%
P/E ratio:
24.96
P/S ratio:
9.89
P/B ratio:
1.85%
Volume:
134K
Avg. volume:
151.7K
1-year change:
-7.5%
Market cap:
$1.3B
Revenue:
$131.3M
EPS:
$2.9
How Much Does Ligand Pharmaceuticals Make?
-
How Much Are Ligand Pharmaceuticals's Sales Annually?
LGND Revenues are $131.3M -
How Much Profit Does Ligand Pharmaceuticals's Make A Year?
LGND net income is $52.2M
Is Ligand Pharmaceuticals Growing As A Company?
-
What Is Ligand Pharmaceuticals's Growth Rate Quarterly?
Quarterly YoY revenue growth is -0.44% -
What Is Ligand Pharmaceuticals's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Ligand Pharmaceuticals Stock Price Performance
-
Did Ligand Pharmaceuticals Stock Go Up Last Month?
Ligand Pharmaceuticals share price went down by -5.87% last month -
Did LGND's Share Price Rise Over The Last Year?
LGND share price fell by -7.5% over the past 1 year
What Is Ligand Pharmaceuticals 52-Week High & Low?
-
What Is Ligand Pharmaceuticals’s 52-Week High Share Price?
Ligand Pharmaceuticals has traded as high as $94.57 over the past 52 weeks -
What Is Ligand Pharmaceuticals’s 52-Week Low Share Price?
Ligand Pharmaceuticals has traded as low as $49.24 over the past 52 weeks
Ligand Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Ligand Pharmaceuticals?
-
How Much Debt Does Ligand Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Ligand Pharmaceuticals Have?
Cash and short term investments quarterly total is $170.3M -
What Is Ligand Pharmaceuticals’s Book Value Per Share?
Book value per share is 39.92
Is Ligand Pharmaceuticals Cash Flow Positive?
-
What Is LGND Cash Flow From Operations?
Cash flow from operations (TTM) is $49.6M -
What Is Ligand Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is -$59.9M -
What Is Ligand Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$11.7M
Ligand Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
LGND return on invested capital is 7.6% -
What Is Ligand Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is 6.71% -
What Is LGND Return On Equity?
ROE is a measure of profitability and is 7.96%
Ligand Pharmaceuticals Earnings Date & Stock Price
-
What Is Ligand Pharmaceuticals's Stock Price Today?
A single share of LGND can be purchased today for 73.38 -
What Is Ligand Pharmaceuticals’s Stock Symbol?
Ligand Pharmaceuticals trades on the nasdaq under the ticker symbol: LGND -
When Is Ligand Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Ligand Pharmaceuticals is scheduled on August 8, 2024 -
When Is LGND's next ex-dividend date?
Ligand Pharmaceuticals's next ex-dividend date is March 11, 2016 -
How To Buy Ligand Pharmaceuticals Stock?
You can buy Ligand Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Ligand Pharmaceuticals Competitors
-
Who Are Ligand Pharmaceuticals's Competitors?
Below is a list of companies who compete with Ligand Pharmaceuticals or are related in some way:
Ligand Pharmaceuticals Dividend Yield
Data Unavailable
Ligand Pharmaceuticals Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 108.85% |
Revenue: | -44.22% | 9.58% |
Analyst Recommendations
Buy Recommendations: | 2 |
---|---|
Hold Recommendations: | 0 |
Sell Recommendations: | 0 |
Price Target: | 116.80 |
Upside from Last Price: | 59.17% |